DR. H. MOLZAHN, Intensieve Geneeskunde SRL
DR. H. MOLZAHN, Intensieve Geneeskunde reported total assets of 600,439 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
By total assets for 2025, DR. H. MOLZAHN, Intensieve Geneeskunde ranks in the top half of the 15,444 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of DR. H. MOLZAHN, Intensieve Geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +45 % Total assets +32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR. H. MOLZAHN, Intensieve Geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 90,390 € | ||||
| Equity | 551,162 € | ||||
| Cash | 496,361 € | ||||
| EBITDA | 141,187 € | ||||
| Total assets | 600,439 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 28 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
DR. H. MOLZAHN, Intensieve Geneeskunde's financial analysis
- Solvency91.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR. H. MOLZAHN, Intensieve Geneeskunde
1 active director(s) in the register.
DR. H. MOLZAHN, Intensieve Geneeskunde's shareholders and holdings →DR. H. MOLZAHN, Intensieve Geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0652.611.941
- VAT number
- BE0652611941
- Peppol
- Registered · 0208:0652611941 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Apr 2016
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
DR. H. MOLZAHN, Intensieve Geneeskunde (SRL) has been based in Leuven since 2016, active in: medical specialists activities. For 2025, it reports a net profit of 90,390 € and equity of 551,162 €; its revenue is not published. Its solvency stands at 91.8%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DR. H. MOLZAHN, Intensieve Geneeskunde
Companies in the same business, of comparable size and area, outside its group.
- Dr. De Wolf Axel, cardiologie Medical specialists activities Leuven · balance sheet 598,244 €
- Med-Anpo Medical specialists activities Lummen · balance sheet 602,916 €
- TNP Medical specialists activities Rixensart · balance sheet 603,178 €
- Dr. Mathieu Spaas Medical specialists activities Ghent · balance sheet 600,346 €
- Dr. Albert LOUIS Medical specialists activities La Bruyère · balance sheet 600,571 €
- Coupure Centrum voor Plastische Chirurgie Medical specialists activities Ghent · balance sheet 601,320 €
- Amariutei - Pneumologie Medical specialists activities Namur · balance sheet 599,557 €
- Cabinet Medical Magda Geerinck Medical specialists activities Philippeville · balance sheet 601,338 €
Frequently asked questions about DR. H. MOLZAHN, Intensieve Geneeskunde
What is the revenue of DR. H. MOLZAHN, Intensieve Geneeskunde?
DR. H. MOLZAHN, Intensieve Geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR. H. MOLZAHN, Intensieve Geneeskunde?
In Belgium, the VAT number is the company number prefixed with BE: BE0652611941 for DR. H. MOLZAHN, Intensieve Geneeskunde, if the company is VAT-registered. Its company number (CBE) is 0652.611.941.
Where is the registered office of DR. H. MOLZAHN, Intensieve Geneeskunde?
According to the CBE register, the registered office of DR. H. MOLZAHN, Intensieve Geneeskunde is in 3001 Leuven.
What is the equity of DR. H. MOLZAHN, Intensieve Geneeskunde?
At the close of the 2025 financial year, the equity of DR. H. MOLZAHN, Intensieve Geneeskunde amounts to 551,162 €, a solvency of 91.8% of total assets.
Who manages DR. H. MOLZAHN, Intensieve Geneeskunde?
The register lists 1 active mandates at DR. H. MOLZAHN, Intensieve Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is DR. H. MOLZAHN, Intensieve Geneeskunde within its sector?
By total assets for 2025, DR. H. MOLZAHN, Intensieve Geneeskunde ranks in the top half of the 15,444 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of DR. H. MOLZAHN, Intensieve Geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →